Probiotics
Features of Changlekang (Oral Clostridium Butyricum and Bifidobacterium Capsule, Live)
☆ First class national new drug
☆ New drug protection of 12 years and patent protection of 20 years
☆ Contains no disputed ingredients of live bacteria
☆ Two liver bacteria coordinate, quick and high effects, green and safe.
☆ Pregnant women and babies can use it safely
Indications
Acute and chronic diarrhea, enteritis, maladjustment of intestinal bacteria-group and dyspepsia arising from antibiotic, chronic hepatitis, etc.
Observation of clinical effects
pH of stool of subjects in middle and high dosage groups falls obviously, which may be related to the settlement and proliferation of clostridium and butyricum in intestinal tract and its increase with dosage rise. Bifidobacterium has a tendency to increase and increase obviously at high dosage level (p<0.05). Enteric bacilli has tendency of decline at middle and high dosage level.
Comparison of diarrhea times before and after treatment
|
Group |
Phase Ⅱ clinical trial |
Phase III clinical trial |
||||
|
n |
Before treatment |
After treatment |
n |
Before treatment |
After treatment |
|
|
Changlekang capsule |
55 |
5.11±2.54 |
1.36±0.91a |
220 |
6.23±2.93 |
1.20±0.66a |
|
Miya tablet |
49 |
6.89±3.68 |
1.49±0.82a |
96 |
5.56±3.07 |
1.16±0.69a |
|
Changlekang powder |
47 |
6.03±3.70 |
1.36±0.64a |
227 |
6.34±3.76 |
1.27±0.58a |
Clinical trial shows that Changlekang is safe and effective in treatment of diarrhea
During the treatment of 90 cases of children suffering from diarrhea with Changlekang powder, the total effectiveness is 96.7% (total effectiveness of regular treatment group is 82.9%), obvious effectiveness of Changlekang group is 70.0% which is clearly better than regular treatment group (54.3%)(P<0.01),the treatment effects are obvious and without side effects.
Changlekang has obvious effects in treating IBS
The trial shows that Changlekang capsule, powder and Miya tablet are equal in treatment of IBS. No adverse reactions are found, so the use of Changlekang for treatment of IBS is effective and safe.
The effects of Changlekang on Neonatal Jaundice
The effects of Changlekang on Neonatal Jaundice The effect is positive. No obvious adverse effect is observed. In addition, the patients eat more. The drug is worthwhile for clinical usage, esp. in grassroot hospitals.
Administration and dosage:
Capsule/powder
1. Orally taken by adults: 3 capsules/bag for each time, twice every day, taken with cold water. 3-7 days of administration for acute diarrhea; 14-21 days of administration for chronic diarrhea or according to doctor's advice.
2. orally taken by children: 1 capsule/bag each time, twice a day or according to doctor's advice, for those who can not swallow capsules, the powder in the capsule can be taken out and administered with cold boiled water, fruit juice or milk.
Pharmacology and toxicology:
The drug effect test in animal body showed that the product can stop the diarrhea of mice caused by ampicillin.
The test in vitro showed that clostridium butyricum can inhibit the growth of several kinds of intestinal pathogenic bacteria such as vibrio cholera biotype Eltor, 01, vibrio cholera 0139, enterohemorrhagic E. coli 0157 and etc. It can also inhibit the growth of shigella dysenteria and hog cholera salmonella.
In phaseⅠ-Ⅲ clinical trial,few patients have slight skin rash and stomach discomfort, the incidence rate of stomach discomfort is 0.88% and incidence rate of slight skin rash is 1.98%. It proves that Changlekang is really a safe drug.
[Product Name]
Oral clostridium butyricum and bifidobacterium capsules/powders, live
[Ingredients]
Clostridium butyricum and bifidobacterium powder
[Character]
The product is capsule/powder containing white or grey white powder
[Indication]
Acute and chronic diarrhea, enteritis, maladjustment of intestinal bacteria-group and dyspepsia arising from antibiotic, chronic hepatitis, etc.
[Administration and dosage]
Capsule/powder
1. orally taken by adults
3 capsules/bag for each time, twice a day, taken with cold boiled water. 3-7 days of administration for acute diarrhea; 14-21 days of administration for chronic diarrhea or according to doctor's advice.
2. orally taken by children
1 capsule/bag each time, twice a day or according to doctor's advice, for those who can not swallow capsules, the powder in the capsule can be taken out and administered with cold boiled water, fruit juice or milk.
[Adverse reactions]
In the clinical study phase I-III, only a few patients shows slight skin rash and slight discomfort in the stomach and can disappear automatically.
[Contra-indications]
patients who are allergic to probiotics.
[Interactions]
The product should not be taken together with antibiotics medicine. The test shows that clostridium butyricum is sensitive to ampicillin, cephazoline, tetracin,chloromycetin, furazolidone, and compound sinomin Bifidabacterium is sensitive to ampicillin, cefotaxime, chloromycetin, furazolidone, and erythromycin.
[Overdose]
No report of toxicity caused by overdose.
[Pharmacology and toxicology]
The drug effect test in animal body showed that the product can stop the diarrhea of mice caused by ampicillin.
The test in vitro showed that clostridium butyricum can inhibit the growth of several kinds of intestinal pathogenic bacteria such as vibrio cholera biotype Eltor, 01 , vibrio cholera 0139, enterohemorrhagic E. coli 0157 and etc. it can also inhibit the growth of shigella dysenteria and hog cholera salmonella.
[Pharmacokinetics]
Clostridium butyricum can stay temporarily in intestinal tract for about 10 days before being discharged out of the body. Bifidobacterium is beneficial bacteria that can stay for long term after being orally administered.
[Indications]
acute diarrhea resulting from acute and non-specific infection, intestinal flora imbalance caused by antibiotics and chronic liver disease and the related acute and chronic diarrhea and dyspepsia.
[Specification]
Each capsule contains 420mg of pharmaceuticals, each bag of powder contains 500mg of pharmaceuticals ( content of live clostridium butyricum is more than 1.0 x 107 CFU/g, content of bifidobacterium is more than 1.0 x 106CFU/g before expiration date).
[Storage]
In shaded area under 2-8 degrees.
[Package]
Capsule: medicinal aluminum foil +PVC package, 420mg/capsule x 12 capsules/box.
Powder: medicinal composite membrane, 500mg/bag x 10 bags/box.
[License No.]
GUOYAOZHUNZI S20020014
GUOYAOZHUNZI S20020015.
[Producer]
Shandong Kexing Bioproducts Co.,Ltd.
Address: Tangwangshan Road, Mingshui Development Zone, Zhangqiu, Shandong–250200, China
Tel: 0086-531- 83316484/83310435
Fax: 0086-531-83311023/3311366
Web Site: www.sdkexing.com
